Literature DB >> 12718885

A p53-dependent checkpoint pathway prevents rereplication.

Cyrus Vaziri1, Sandeep Saxena, Yesu Jeon, Charles Lee, Kazutaka Murata, Yuichi Machida, Nikhil Wagle, Deog Su Hwang, Anindya Dutta.   

Abstract

Eukaryotic cells control the initiation of DNA replication so that origins that have fired once in S phase do not fire a second time within the same cell cycle. Failure to exert this control leads to genetic instability. Here we investigate how rereplication is prevented in normal mammalian cells and how these mechanisms might be overcome during tumor progression. Overexpression of the replication initiation factors Cdt1 and Cdc6 along with cyclin A-cdk2 promotes rereplication in human cancer cells with inactive p53 but not in cells with functional p53. A subset of origins distributed throughout the genome refire within 2-4 hr of the first cycle of replication. Induction of rereplication activates p53 through the ATM/ATR/Chk2 DNA damage checkpoint pathways. p53 inhibits rereplication through the induction of the cdk2 inhibitor p21. Therefore, a p53-dependent checkpoint pathway is activated to suppress rereplication and promote genetic stability.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12718885     DOI: 10.1016/s1097-2765(03)00099-6

Source DB:  PubMed          Journal:  Mol Cell        ISSN: 1097-2765            Impact factor:   17.970


  179 in total

1.  Cdc6 chromatin affinity is unaffected by serine-54 phosphorylation, S-phase progression, and overexpression of cyclin A.

Authors:  Mark G Alexandrow; Joyce L Hamlin
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

2.  Intra-S-phase checkpoint activation by direct CDK2 inhibition.

Authors:  Yonghong Zhu; Carmen Alvarez; Ronald Doll; Hirokazu Kurata; Xiao Min Schebye; David Parry; Emma Lees
Journal:  Mol Cell Biol       Date:  2004-07       Impact factor: 4.272

3.  Interaction of the S-phase cyclin Clb5 with an "RXL" docking sequence in the initiator protein Orc6 provides an origin-localized replication control switch.

Authors:  Gwendolyn M Wilmes; Vincent Archambault; Richard J Austin; Matthew D Jacobson; Stephen P Bell; Frederick R Cross
Journal:  Genes Dev       Date:  2004-04-22       Impact factor: 11.361

4.  HBx protein of hepatitis B virus promotes reinitiation of DNA replication by regulating expression and intracellular stability of replication licensing factor CDC6.

Authors:  Vijaya Pandey; Vijay Kumar
Journal:  J Biol Chem       Date:  2012-04-19       Impact factor: 5.157

5.  Chromatin remodeler sucrose nonfermenting 2 homolog (SNF2H) is recruited onto DNA replication origins through interaction with Cdc10 protein-dependent transcript 1 (Cdt1) and promotes pre-replication complex formation.

Authors:  Nozomi Sugimoto; Takashi Yugawa; Masayoshi Iizuka; Tohru Kiyono; Masatoshi Fujita
Journal:  J Biol Chem       Date:  2011-09-20       Impact factor: 5.157

6.  Specific replication origins promote DNA amplification in fission yeast.

Authors:  Lee Kiang; Christian Heichinger; Stephen Watt; Jürg Bähler; Paul Nurse
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

Review 7.  DNA replication licensing control and rereplication prevention.

Authors:  Chonghua Li; Jianping Jin
Journal:  Protein Cell       Date:  2010-02-23       Impact factor: 14.870

Review 8.  APC/C-Cdh1: from cell cycle to cellular differentiation and genomic integrity.

Authors:  Xinxian Qiao; Liyong Zhang; Armin M Gamper; Takeo Fujita; Yong Wan
Journal:  Cell Cycle       Date:  2010-10-11       Impact factor: 4.534

9.  A chrysin derivative suppresses skin cancer growth by inhibiting cyclin-dependent kinases.

Authors:  Haidan Liu; Kangdong Liu; Zunnan Huang; Chan-Mi Park; N R Thimmegowda; Jae-Hyuk Jang; In-Ja Ryoo; Long He; Sun-Ok Kim; Naomi Oi; Ki Won Lee; Nak-Kyun Soung; Ann M Bode; Yifeng Yang; Xinmin Zhou; Raymond L Erikson; Jong-Seog Ahn; Joonsung Hwang; Kyoon Eon Kim; Zigang Dong; Bo-Yeon Kim
Journal:  J Biol Chem       Date:  2013-07-25       Impact factor: 5.157

Review 10.  In the wrong place at the wrong time: does cyclin mislocalization drive oncogenic transformation?

Authors:  Jonathan D Moore
Journal:  Nat Rev Cancer       Date:  2013-02-07       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.